SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Jeff Collins to serve as a judge for the 2nd Carolina Entrepreneurial Initiative Challenge
News | 04. 22. 2006
